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1. Introduction 
Adenosine inhibits stimulated forms of adenylate 
cyclase non-competitively with respect to met&ATP 
substrate [ 1,2] and increases Mg2+ ion affinity at the 
divalent cation binding site [ 21. This inhibitory effect 
of adenosine is mediated by the ‘P’-site* and is evi- 
dent in the absence of a functional guanine nucleo- 
tide regulatory component [3]. Thus, the suggestion 
was made that this inhibitory site for adenosine is 
located on the catalytic subunit of the cyclase [3]. 
However, since all adenylate cyclases are not inhib- 
ited by adenosine [4,5], the participation of addi- 
tional subunits remains possible. To help distinguish 
between these alternatives and to approach the prob- 
lem of isolating the component(s) mediating adeno- 
sine inhibitiori, we have utilized the ‘P’-site affinity of 
the cyclase for the partial purification of the enzyme 
by affinity chromatography. The results of these 
studies are presented in this report. 
homogenizing media and sucrose solutions. The 
EDTA was subsequently removed by repetitive cen- 
trifugation-resuspension; prior to storage of mem- 
branes at -7O’C. 
Washed particulate and Lubrol-PX-dispersed aden- 
ylate cyclases were prepared from cerebellum [7]. 
The dispersed enzyme was concentrated about 
12-fold by ultrafiltration (Amicon PM-l 0) and was 
chromatographed on DEAE-Sephadex as in [8]. 
2.2. Adenyh te cyche assay 
Adenylate cyclase activity was determined [2] in a 
reaction mixture containing 50 mM glycylglycine 
(pH 7.5), 1 mM 3-isobutyl-1-methylxanthine (IBMX), 
100 m MnATP, 400-800 PM excess MnC12, [cK-~~P]- 
ATP [9] (OS-l.5 X lo6 cpm), 2 mM purified creatine 
phosphate [ 61, creatine kinase (100 pg/ml), and myo- 
kinase (100 pg/ml) in a volume of 200 /.d. Reactions 
were for 2 min at 37°C and were initiated by the addi- 
tion of enzyme. Reactions were stopped by the 
ZnC03 precipitation method [lo] and the labelled 
CAMP was purified as in [ 111. 
2. Materials and methods 
2.1. Enzyme preparation 3. Results 
Partially purified plasma membranes were pre- 
pared from rat liver as in [6], with 5 mM EDTA in 
* Effects of various analogs of adenosine on cellular CAMP 
levels and adenylate cyclase activity have suggested the 
presence of distinct binding sites for adenosine. High affin- 
ity sites.requiring an intact ribose moiety have been found 
to activate or inhibit various adenylate cyclases. These 
opposing effects on adenylate cyclase have led to the desig- 
nation of ‘R’-site subclasses, R, and Ri [ 181, or A, and A, 
[ 191, for activation and inhibition, respectively. Ri(A,) 
sites are high affinity inhibitory receptors that are distinct 
from low affinity ‘P’-sites. In this paper we have adopted 
the designation (Ra and P) of [ 181 
To optimize inhibition of adenylate cyclase by 
adenosine prior to solubilization, we thought we could 
take advantage of the striking sensitizing effect of hor- 
mone stimulation. Although stimulation of the plate- 
let enzyme by prostaglandin El (PGE,) decreased the 
Ki from >I mM for basal activity to -10 PM [2], 
Londos and Preston [l] did not observe such a sensi- 
tization by glucagon of the liver enzyme. However, in 
contrast with [ 11, we found.marked and varied effects 
of modulators on the enzyme’s sensitivity to inhibition 
by the nucleoside (fig.1). As expected, basal activity 
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Fig.1. Effects of modulators of liver adenylate cyclase on sen- 
sitivity to inhibition by adenosine. Activity was determined 
with 100 PM MnATP and 400 PM MnCl,. Values are ratios of 
CAMP accumulation with adenosine to that without adenosine. 
was marginally suppressed by adenosine, with <20% 
inhibition observed with 2 mM adenosine. However, 
activity stimulated by F- or glucagon + GTP was sig- 
nificantly more sensitive to adenosine inhibition, with 
5% inhibition observed with 75--2OOpM. The enzyme 
stimulated by 100 /.&i guanosine 5’- [/.3,7-imido] tri- 
phosphate (GPP[NH]P) t glucagon was considerably 
less sensitive to inhibition, whereas the enzyme stimu- 
lated by GPP[NH]P alone was actually enhanced 
about 2-fold by adenosine (fig. 1, upper panel). 
In other experiments we found that GTP alone did 
not enhance sensitivity to inhibition by adenosine 
and that PGEr, which stimulated the liver cyclase 
about 3-fold (not shown), caused an increase in sensi- 
tivity to inhibition equivalent to that shown in fig.1 
for glucagon or F-. At concentrations from O.l- 
100 PM, CAMP did not increase sensitivity to inhibition 
by adenosine. Thus, the extents of stimulation by the 
various agents were quite different and there was no 
evidence for a correlation between the extent of 
stimulation of adenylate cyclase and its sensitivity to 
inhibition by adenosine. 
The contrasting effect of Gpp[NH]P to elicit stim- 
ulation by adenosine was curious since the conditions 
(1 mM IBMX) precluded stimulation through adeno- 
sine ‘R,‘-sites. Not only did adenosine appear to 
shorten the lag phase of GPP[NH]P activation, but 
also a distinct transition from stimulation by adeno- 
sine to inhibition was observed as activation by 
GZY[NH]P proceeded (fig.2, lower panel). The gen- 
eral character of this developing inhibition was less a 
function of the adenosine concentration than of time 
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Fig.2. Time-dependent effects of CPP[NH]P on adenosine 
modulation of liver adenylate cyclase. Upper panel: CAMP 
accumulation was measured with 100 MM MgATP, 4 mM 
MgCl,, 100 NM GPP[NH]P, and the indicated concentrations 
of adenosine. Values are ratios of CAMP accumulation with 
adenosine to that without adenosine. Lower panel: CAMP 
accumulation was measured with 100 PM MnATP, 400 nM 
MnCl,, 100 nM GPP[NH]P, and 300 PM adenosine as indi- 
cated. 
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Table 1 
Retention of adenosine inhibition following preactivation and solubilization of hepatic adenylate 
cyclase 
Enzyme Adenosineb 
(300 PM) 
Pretreatment conditionsa 
NaF GI’P[NH]P GPJ’[ NH]P + GPP[NH]P + 
Glucagon Glucagon + NaF 
pmol CAMP formed (2 min . mg protein)-l 
After treatment - 1630 1400 2250 2510 
(30°C for 30 min) + 432 535 154 781 
v+Iv_ 0.27 0.38 0.34 0.31 
Lubrol-PX 
SupernateC 
- 2680 2010 2410 3460 
+ 1140 842 1140 1450 
v+lv_ 0.43 0.42 0.41 0.42 
a Liver plasma membranes (1.5 mg protein/ml) were pretreated for 30 min at 3O’C in 700 ~1 contain- 
ing 50 mM glycylglycine (pH 7.5), 10 mM MgCl,, and 10 mM NaF, 100 PM GPP[NH]P, or 1 PM glu- 
cagon as indicated. Aliquots (20 ~1) were taken for assay of adenylate cyclase as in section 2 
b Activities were determined without or with 300 PM adenosine in the reaction mixture. v+/v_ indi- 
cates the ratio of activity determined with adenosine (+) to that determined without adenosine (-) 
’ To 500 ~1 aliquots of membranes pretreated as under (a) was added 1 ml of 1% (w/v) Lubrol-PX. 
The mixtures were homogenized with 10 passes of a Teflon-plastic homogenizer and were then cen- 
trifuged at 29 000 X g, rav, for 30 min. Supematant fractions were then assayed for adenylate cyclase 
and therefore was a characteristic of GPP[NH]P action 
(fig.2, upper panel). 
Since stimulation of adenylate cyclase by F- or 
GPP[NH]P results in increased sensitivity to inhibi- 
tion by adenosine, and since pretreatment with these 
agents also leads to stable activation of the enzyme, it 
was necessary to ascertain that inhibition occurred 
after preactivation of the cyclase and also after its dis- 
persion by detergent. Adenosine inhibited liver aden- 
ylate cyclase that had been preactivated with Mg2+ 
and F-, or with GPP[NH]P, without or with glucagon 
(table 1). When the preactivated enzyme was dispersed 
into a 29 000 X g supernatant fraction, it retained 
sensitivity to inhibition by adenosine. Preincubation 
with the combination of agents (Mg*, F-, GI’P[NH]P, 
glucagon) always led to the greatest activity, which 
was also reflected in the activity seen after solubili- 
zation. 
We observed a similar inhibition by adenosine of 
the detergent-dispersed enzyme from rat brain 
(table 2). The brain cyclase is principally a calmodu- 
lin-Cal+-regulated enzyme which can be made defi- 
cient in calmodulin and functionally deficient in the 
guanine nucleotide regulatory component by chroma- 
tography of the dispersed enzyme on DEAE-Sephadex 
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in the presence of chelator [8,12]. While an enzyme 
treated in this manner is an essentially Mn2+-depen- 
dent enzyme, unresponsive to F- or GPP[NH]P 
[ 12,131, we found that it retained sensitivity to inhi- 
bition by adenosine (table 2). Thus, preactivated 
and/or dispersed adenylate cyclases from either brain 
or liver are inhibited by adenosine. 
These and earlier [3] studies suggest he possibility 
that adkosine ‘P’-site inhibition may be a direct effect 
on the catalytic subunit of the cyclase, whereas the 
Table 2 
Effect of adenosine on soluble enzyme from rat brain 
Additions Control 300 PM Average 
Adenosine vado/vcont 
nmol CAMP (10 min . mg protein)-’ 
None 31.2,44.4a 13.8,18.6 0.43 
NaF (10 mM) 32.7,44.1 13.5,20.5 0.44 
G.?Y’[NH]P (100rM) 25.7, 37.9 13.2,18.4 0.50 
a Activity was determined with 100 9M MnATP, 800 IBM 
MnC1,,‘0.5 mg bovine serum albumin per ml, 3 mM dithio- 
threitol, and otherwise as in section 2. Values are from two 
different enzyme preparations, in different experiments, 
each assayed in triplicate 
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Table 3 
Partial purification of hepatic adenylate cyclase on adenosine agarose 
Enzyme Protein Adenylate cyclase activitya 
Total Specific 
mg nmol/min nmol (min . mg)-’ 
After preactivation and 
solubilization 1.00 0.76 0.76b 
First supernateC 0.40 0.14 0.34 
Adenosine-wash supernate 0.08 0.31 3.73 
a Liver plasma membranes were preactivated and solubilized as described for 
table 1 with MgCl,, GPP[NH]P, glucagon, and NaF. Lubrol-PX was added to a 
final concentration of 1.2%, giving a detergent/protein ratio of 6 
b The specific activity of 0.76 was obtained with 190 nM adenosine, the concen- 
tration carried into the assay from the adenosine-wash supernatant fraction. 
Without adenosine initial activity was 1.76 
’ One ml aliquots of solubilized adenylate cyclase was mixed with 1 ml adeno- 
sine(C+agarose and was rotated for 15 min at 4°C. The agarose suspension 
was centrifuged and the supernatant fraction (1 ml) was removed and used as 
‘first supernate’. The agarose was then washed with 3 ml of 25 mM glycylglycine 
(pH 7..5), and was again centrifuged. The second supernatant fraction was dis- 
carded. Then 1 ml of 1 mM adenosine was added and the suspension was again 
centrifuged. The resulting supernatant fraction (Adenosine-wash) was assayed 
for protein and cyclase 
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lack of effect of adenosine in other systems [4,5] sug- 
gests the possible participation of additional compo- 
nents. To approach this question detergent-dispersed 
adenylate cyclase was chromatographed on p-and 
C-8-linked adenosine-hexane-agaroses. When liver 
adenylate cyclase was preactivated and dispersed as 
per table 1, or detergent-dispersed cerebellar cyclase 
was either treated batch-wise or applied to a column 
of adenosine-agarose, significant adenylate cyclase 
activity bound. In experiments with adenosine(C-8) 
agarose 86 * 7% (n = 5) of applied activity, but only 
33 f 10% of the protein bound. With a 5’-AMP-agarose 
as a control, only 37 + 9% (n = 4) of applied activity 
and 22 + 14% of applied protein bound. An example 
of such an experiment is shown in table 3. In the 
experiment shown 92% of applied activity and 60% 
of applied protein bound to the adenosine-agarose. 
When the agarose was washed with buffer containing 
1 mM adenosine, 41% of applied activity could be 
eluted and resulted in a 5-fold increase in adenylate 
cyclase specific activity. In no instance was the aden- 
ylate cyclase, which either bound or did not bind to 
the adenosine-agaroses, rendered insensitive to inhibi- 
tion by adenosine by this treatment. 
4. Discussion 
The data presented in this report suggest several 
conclusions regarding the locus and mechanisms 
mediating inhibition of adenylate cyclase by adeno- 
sine. First, the enhancing effect that stimulatory 
agents have on adenosine inhibition may well be due 
to their combined effects to increase metal ion affin- 
ity of adenylate cyclase. Adenosine inhibition of 
adenylate cyclase is metal dependent and is accompa- 
nied by a 20-fold increase in the enzyme’s affinity for 
free metal at its divalent cation site [2]. Seemingly 
paradoxically, activation of the liver cyclase by F-, 
glucagon + GTP, or, with time, GPP[NH]P, is also 
coincident with a decrease in the apparent Km of the 
enzyme for free metal (e.g., [ 14-171). Thus, it may not 
be the degree of stimulation of adenylate cyclase that 
would correlate with increased sensitivity to inhibi- 
tion by adenosine, but rather the degree to which 
metal ion affinity may be increased. 
Second, sensitivity to inhibition by adenosine was 
retained following preactivation of the liver cyclase 
by Mg’+ t F- and/or GPP[NH]P + glucagon and was 
retained following its subsequent dispersion with 
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Lubrol-PX. Thus, the molecular configuration of 
adenylate cyclase elicited by these agents, allowing 
the stable activation of the enzyme, also allows for 
inhibition by adenosine. 
Third, adenosine affinity chromatography may be 
a useful addition to other methods for the purifica- 
tion of adenylate cyclase. Detergent-dispersed enzyme 
from both brain and liver bound to and could be par- 
tially purified on adenosine-agaroses. It may be that 
by the use of adenosine analogs as insolubilized ligands 
which exhibit higher affinity and specificity for the 
'P'-site than adenosine, e.g. 2',5'-dideoxyadenosine, a 
considerably greater degree of purification than that 
shown here could be attained. 
And fourth, since adenosine was also found to 
inhibit a brain cyclase which had been made function- 
ally deficient in the guanine nucleotide regulatory 
component [8,12,13], this component appears unne- 
cessary for 'P'-site inhibition by adenosine, consistent 
with [3]. Thus, the data suggest that either adenosine 
inhibits the catalytic subunit directly, or that the 
component mediating inhibition of adenylate cyclase 
is tightly bound to it. 
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